MEDIFAST INC Quarterly Operating Income (Loss) in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Medifast Inc quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q3 2024.
  • Medifast Inc Operating Income (Loss) for the quarter ending September 30, 2024 was $2.11M, a 91.7% decline year-over-year.
  • Medifast Inc Operating Income (Loss) for the twelve months ending September 30, 2024 was $10.8M, a 92.8% decline year-over-year.
  • Medifast Inc annual Operating Income (Loss) for 2023 was $126M, a 31.6% decline from 2022.
  • Medifast Inc annual Operating Income (Loss) for 2022 was $185M, a 14.5% decline from 2021.
  • Medifast Inc annual Operating Income (Loss) for 2021 was $216M, a 61.2% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $10.8M $2.11M -$23.4M -91.7% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-04
Q2 2024 $34.2M -$7.88M -$46.6M -120% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-05
Q1 2024 $80.8M $7.94M -$45.6M -85.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-29
Q4 2023 $126M $8.68M -$23.9M -73.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-20
Q3 2023 $150M $25.5M -$22.6M -47% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-04
Q2 2023 $173M $38.7M -$10.3M -21% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-05
Q1 2023 $183M $53.5M -$1.58M -2.86% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-29
Q4 2022 $185M $32.6M -$14.2M -30.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-20
Q3 2022 $199M $48.2M -$7.02M -12.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 $206M $49M -$12.5M -20.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 $219M $55.1M +$2.29M +4.33% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-01
Q4 2021 $216M $46.8M +$8.87M +23.4% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-20
Q3 2021 $207M $55.2M +$10.6M +23.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $197M $61.4M +$33.3M +119% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 $163M $52.8M +$29.3M +124% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-02
Q4 2020 $134M $38M +$19.3M +103% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-21
Q3 2020 $115M $44.6M +$24.3M +120% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $90.6M $28.1M +$744K +2.72% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 $89.9M $23.5M -$1.18M -4.78% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q4 2019 $91M $18.7M -$1.1M -5.54% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-23
Q3 2019 $92.1M $20.3M +$2.8M +16% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-03
Q2 2019 $89.3M $27.4M +$10.2M +59.9% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $79.1M $24.7M +$10M +68.3% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 $69.1M $19.8M +$10.3M +109% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-26
Q3 2018 $58.7M $17.5M +$7.24M +70.8% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 $51.5M $17.1M +$5.8M +51.3% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-02
Q1 2018 $45.7M $14.7M +$6.07M +70.6% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-02
Q4 2017 $39.6M $9.49M +$2.87M +43.4% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-02
Q3 2017 $36.8M $10.2M +$1.27M +14.2% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 $35.5M $11.3M +$6.29M +125% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-06
Q1 2017 $29.2M $8.61M +$2.34M +37.3% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-04
Q4 2016 $26.9M $6.61M +$1.08M +19.5% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-01
Q3 2016 $25.8M $8.95M +$978K +12.3% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 $24.8M $5.02M -$3.64M -42% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 $28.4M $6.27M -$244K -3.75% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 $28.7M $5.53M +$1.35M +32.3% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-16
Q3 2015 $27.3M $7.98M +$1.39M +21% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 $25.9M $8.66M -$1.2M -12.1% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 $27.1M $6.51M -$3.1M -32.2% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 $30.2M $4.18M -$7.66M -64.7% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-16
Q3 2014 $37.9M $6.59M -$759K -10.3% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 $38.7M $9.86M -$780K -7.33% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 $39.4M $9.61M +$1.03M +12% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q4 2013 $38.4M $11.8M +$4.37M +58.4% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-15
Q3 2013 $34M $7.35M -$1.58M -17.7% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-10
Q2 2013 $35.6M $10.6M +$6.04M +131% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-11
Q1 2013 $29.6M $8.58M +$2.44M +39.8% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
Q4 2012 $27.1M $7.48M +$5.97M +395% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-16
Q3 2012 $21.2M $8.93M +$2.22M +33.1% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 $19M $4.6M -$4.46M -49.2% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-09
Q1 2012 $23.4M $6.14M -$3.97M -39.3% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-10
Q4 2011 $27.4M $1.51M Oct 1, 2011 Dec 31, 2011 10-K 2014-03-17
Q3 2011 $6.71M -$2.34M -25.8% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-09
Q2 2011 $9.06M -$199K -2.15% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-09
Q1 2011 $10.1M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-10
Q3 2010 $9.05M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-09
Q2 2010 $9.26M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.